𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GRB7 protein over-expression and clinical outcome in breast cancer

✍ Scribed by Betsy Ramsey; Tao Bai; Amy Hanlon Newell; Megan Troxell; Byung Park; Susan Olson; Edward Keenan; Shiuh-Wen Luoh


Publisher
Springer US
Year
2010
Tongue
English
Weight
364 KB
Volume
127
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Neuronal protein synuclein Ξ³ predicts po
✍ Jianping Guo; Chengchao Shou; Lin Meng; Beihai Jiang; Bin Dong; Lihua Yao; Yunta πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 508 KB

## Abstract Synuclein Ξ³ (SNCG), previously identified as a breast cancer‐specific gene (BCSG1), is highly expressed in breast carcinomas but not in normal epithelium. SNCG regulates many pathways in growth and progression of breast cancer. To determine if SNCG is a biomarker for clinical prognosis

Polycomb group protein EZH2 is frequentl
✍ Yun Gong; Lei Huo; Ping Liu; Nour Sneige; Xiaoping Sun; Naoto T. Ueno; Anthony L πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

## Abstract ## BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of polycomb group proteins, is involved in the regulation of cell cycle progression and has been implicated in various human malignancies, including breast cancer, and also has been associated with aggressive tumor behavior. H

Up-regulation of the protein tyrosine ph
✍ Sonia S. Yip; A. Jayne Crew; Julia M.W. Gee; Rina Hui; Roger W. Blamey; John F.R πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 134 KB πŸ‘ 2 views

The protein tyrosine phosphatase SHP-1 is predominantly expressed in hemopoietic cell lineages, where its function is relatively well defined. However, its expression profile also extends to certain epithelial cell types. Furthermore, the negative regulatory role of this enzyme in hemopoietic cell s